Wellington Management Group’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350M Buy
7,260,287
+138,303
+2% +$9.47M 0.07% 259
2025
Q4
$495M Buy
7,121,984
+1,432,797
+25% +$58.5M 0.09% 206
2025
Q3
$159M Sell
5,689,187
-1,186,582
-17% -$23.6M 0.03% 439
2025
Q2
$143M Sell
6,875,769
-915,414
-12% -$20.1M 0.03% 440
2025
Q1
$135M Buy
7,791,183
+5,569
+0.1% +$136K 0.03% 443
2024
Q4
$211M Buy
7,785,614
+15,843
+0.2% +$562K 0.04% 358
2024
Q3
$341M Buy
7,769,771
+221,851
+3% +$8.58M 0.06% 274
2024
Q2
$296M Buy
7,547,920
+1,720,264
+30% +$70.6M 0.05% 300
2024
Q1
$250M Buy
5,827,656
+1,455,330
+33% +$61.4M 0.04% 349
2023
Q4
$178M Buy
4,372,326
+3,504,747
+404% +$201M 0.03% 418
2023
Q3
$43.7M Buy
867,579
+657,310
+313% +$21.2M 0.01% 724
2023
Q2
$8.74M Buy
210,269
+110,370
+110% +$3.09M ﹤0.01% 1135
2023
Q1
$2.38M Buy
+99,899
New +$2.35M ﹤0.01% 1472

Other funds holding GPCR